|

Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma

RECRUITINGEarly 1Sponsored by Oslo University Hospital
Actively Recruiting
PhaseEarly 1
SponsorOslo University Hospital
Started2023-03-01
Est. completion2024-12
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05043701

Summary

A study to determine the feasibility and safety of individualized cancer stem cell targeted therapy based on high-throughput functional profiling of FDA/EMA-approved drugs in patients with GBM that has recurred or progressed following standards-of-care (RT, TMZ).

Eligibility

Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Recurrence of histologically verified glioblastoma
* Adequate biopsy to generate enough live cells to allow functional screening
* Must be ambulatory with an Eastern Cooperative Oncology Group (ECOG) performance status 0-1
* Must be 18 to 70 years of age
* Adequate bone marrow, liver and heart function
* Must be competent to give consent
* Signed informed consent and expected cooperation of the patients for the treatment and follow up must be obtained and documented according to International Conference on Harmonization Good Clinical Practice guidelines (ICH GCP), and national/local regulations.

Exclusion Criteria:

* Patients taking part in other clinical trials which could make inclusion or follow-up difficult
* Any reason why, in the opinion of the investigator, the patient should not participate

Conditions2

CancerRecurrent Glioblastoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.